Hepatitis C virus seroprevalence in adults in Africa: A systematic review and meta-analysis

Journal of Viral Hepatitis

Volumn 23, Issue 4, 2016, Pages 244-255

  Riou, J ^a   Ait Ahmed M ^a   Blake, A ^a   Vozlinsky, S ^a   Brichler, S ^b,c   Eholie S ^d   Boelle P Y ^b,e   Fontanet, A ^a,f  

^a INSTITUT PASTEUR   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM U955   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^e INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

^f University of Paris Cité   (France)

Author keywords

Africa; epidemiology; hepatitis C; meta analysis; prevalence

Indexed keywords

ALGERIA; ANGOLA; BENIN; BLOOD DONOR; BOTSWANA; BURKINA FASO; BURUNDI; CAMEROON; CAPE VERDE; CENTRAL AFRICAN REPUBLIC; CHAD; COMOROS; COTE D'IVOIRE; DEMOCRATIC REPUBLIC CONGO; DJIBOUTI; EGYPT; EQUATORIAL GUINEA; ERITREA; ETHIOPIA; GABON; GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KENYA; LESOTHO; LIBERIA; LIBYAN ARAB JAMAHIRIYA; MADAGASCAR; MALAWI; MALI; MAURITANIA; MAURITIUS; META ANALYSIS; MOROCCO; MOZAMBIQUE; NAMIBIA; NIGER; NIGERIA; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; RWANDA; SAO TOME AND PRINCIPE; SENEGAL; SEROPREVALENCE; SIERRA LEONE; SOMALIA; SOUTH AFRICA; SUDAN; SWAZILAND; SYSTEMATIC REVIEW; TANZANIA; TOGO; TUNISIA; UGANDA; ZAMBIA; ZIMBABWE; ADULT; AFRICA; HEPACIVIRUS; IMMUNOLOGY;

ADULT; AFRICA; HEPACIVIRUS; HEPATITIS C; HUMANS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84960353695     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12481     Document Type: Review

References (41)

1. WHO Sixty-seventh World Health Assembly [Internet]. WHO. at http://www.who.int/mediacentre/events/2014/wha67/en/ (accessed 22 August 2014).
2. Pawlotsky J-M,. New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology 2014; 146: 1176-1192.
3. Jayasekera CR, Barry M, Roberts LR, Nguyen MH,. Treating hepatitis C in lower-income countries. N Engl J Med 2014; 370: 1869-1871.
4. WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection [Internet]. WHO. 2014 at http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/ (accessed 15 January 2015).
5. Guerra J, Garenne M, Mohamed MK, Fontanet A,. HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat 2012; 19: 560-567.
6. Daw MA, El-Bouzedi A,. In association with Libyan Study Group of Hepatitis & HIV. Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey. BMC Infect Dis 2014; 14: 17.
7. Madhava V, Burgess C, Drucker E,. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002; 2: 293-302.
8. Lavanchy D,. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17: 107-115.
9. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST,. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342.
10. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H,. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61: S45-S57.
11. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
12. Bates D, Maechler M, Bolker B, Walker S,. lme4: Linear mixed-effects models using Eigen and S4 [Internet]. 2014 at http://CRAN.R-project.org/package=lme4 (accessed 8 October 2015).
13. R Core Team. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing, 2013. at http://www.R-project.org/
14. Schwarzer G,. meta: Meta-Analysis with R [Internet]. 2013; at http://CRAN.R-project.org/package=meta (accessed 8 October 2015).
15. Wickham H,. ggplot2: elegant graphics for data analysis [Internet]. Springer; 2009. at http://had.co.nz/ggplot2/book (accessed 8 October 2015).
16. Cornberg M, Razavi HA, Alberti A, et al,. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011; 31 (Suppl. 2): 30-60.
17. Schmid GP, Buvé A, Mugyenyi P, et al,. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 2004; 363: 482-488.
18. Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS,. Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis 2015; 15: 819-824.
19. Mumtaz GR, Weiss HA, Thomas SL, et al,. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS Med 2014; 11: e1001663.
20. Jiang J,. Linear and Generalized Linear Mixed Models and Their Applications [Internet]. New York: Springer, 2007. at http://www.springer.com/statistics/statistical+theory+and+methods/book/978-0-387-47941-5 (accessed 18 June 2014).
21. United Nations. World Population Prospects, the 2010 Revision. [Internet]. at http://esa.un.org/unpd/wpp/Excel-Data/population.htm (accessed 15 March 2014)
22. Chatterjee S, Lahiri P,. A simple computational method for estimating mean squared prediction error in general small-area model. In: Proceedings of the section on survey research methods. 2007: 3486-3493.
23. Hall P, Maiti T,. On parametric bootstrap methods for small area prediction. J R Stat Soc Ser B Stat Methodol 2006; 68: 221-238.
24. Frank C, Mohamed MK, Strickland GT, et al,. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. The Lancet 2000; 355: 887-891.
25. Pepin J, Lavoie M, Pybus OG, et al,. Risk factors for hepatitis C virus transmission in colonial Cameroon. Clin Infect Dis 2010; 51: 768-776.
26. Njouom R, Frost E, Deslandes S, et al,. Predominance of hepatitis C virus genotype 4 infection and rapid transmission between 1935 and 1965 in the Central African Republic. J Gen Virol 2009; 90: 2452-2456.
27. Iles JC, Abby Harrison GL, Lyons S, et al,. Hepatitis C virus infections in the Democratic Republic of Congo exhibit a cohort effect. Infect Genet Evol 2013; 19: 386-394.
28. Ndong-Atome GR, Makuwa M, Ouwe-Missi-Oukem-Boyer O, et al,. High prevalence of hepatitis C virus infection and predominance of genotype 4 in rural Gabon. J Med Virol 2008; 80: 1581-1587.
29. Nerrienet E, Pouillot R, Lachenal G, et al,. Hepatitis C virus infection in cameroon: a cohort-effect. J Med Virol 2005; 76: 208-214.
30. Ugbebor O, Aigbirior M, Osazuwa F, Enabudoso E, Zabayo O,. The prevalence of hepatitis B and C viral infections among pregnant women. N Am J Med Sci 2012; 3: 238-241.
31. Oje OJ, Sule WF, Famurewa D,. Dual positivity of hepatitis B surface antigen and anti-hepatitis C virus antibody and associated factors among apparently healthy patients of Ekiti State, Nigeria. Viral Immunol 2012; 25: 448-455.
32. Ezzikouri S, Pineau P, Benjelloun S,. Hepatitis C virus infection in the Maghreb region. J Med Virol 2013; 85: 1542-1549.
33. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ,. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis 2013; 13: 288.
34. Ndong-Atome GR, Makuwa M, Njouom R, et al,. Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa. BMC Infect Dis 2008; 8: 82.
35. Njouom R, Caron M, Besson G, et al,. Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, central Africa. PLoS ONE 2012; 7: e42002.
36. Seeff LB,. Natural history of chronic hepatitis C. Hepatology 2002; 36: s35-s46.
37. Vallet-Pichard A, Mallet V, Nalpas B, et al,. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007; 46: 32-36.
38. Castera L,. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012; 142: 1293-1302.e4.
39. Mullis CE, Laeyendecker O, Reynolds SJ, et al,. High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda. Clin Infect Dis 2013; 57: 1747-1750.
40. Rouet F, Chaix ML, Inwoley A, et al,. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: the ANRS 1236 study. J Med Virol 2004; 74: 34-40.
41. Fick M, Hirschler B,. Gilead offers Egypt new hepatitis C drug at 99 percent discount [Internet ]. Reuters. 2014 at http://www.reuters.com/article/2014/03/21/us-hepatitis-egypt-gilead-sciences-idUSBREA2K1VF20140321 (accessed 18 August 2014)